Nexalin Technology is a medical devices business based in the US. Nexalin Technology shares (NXL) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.63 – a decrease of 10.76% over the previous week. Nexalin Technology employs 6 staff and has a trailing 12-month revenue of around $150,159.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.63 |
|---|---|
| 52-week range | $0.25 - $4.05 |
| 50-day moving average | $0.92 |
| 200-day moving average | $0.94 |
| Wall St. target price | N/A |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.72 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.63 from 2024-10-03
| 1 week (2024-09-27) | -10.76% |
|---|---|
| 1 month (2024-09-04) | -33.50% |
| 3 months (2024-07-03) | -55.00% |
| 6 months (2024-04-04) | -70.70% |
| 1 year (2023-10-04) | 61.95% |
|---|---|
| 2 years (2022-10-04) | -43.75% |
| 3 years (2021-09-30) | N/A |
| 5 years (2019-09-30) | N/A |
| Revenue TTM | $150,159 |
|---|---|
| Gross profit TTM | $958,145 |
| Return on assets TTM | -118.92% |
| Return on equity TTM | -202.23% |
| Profit margin | 0% |
| Book value | $0.18 |
| Market Capitalization | $7.1 million |
TTM: trailing 12 months
Over the last 12 months, Nexalin Technology's shares have ranged in value from as little as $0.2528 up to $4.05. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Nexalin Technology's is 5.708. This would suggest that Nexalin Technology's shares are significantly more volatile than the average for this exchange and represent a higher risk.
To put Nexalin Technology's beta into context you can compare it against those of similar companies.
Nexalin Technology, Inc. , a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas. .
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
These are the best day trading platforms, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
What you need to know about investing in the leading indicator for the overall US stock market.
Check out the best-performing ETFs so far in 2024.